Author

Haowen Tan

Institution: Wuzhou Red Cross Hospital

Observed institution: Wuzhou Red Cross Hospital

ORCID: 0009-0007-0754-3373

Observed ORCID: 0009-0007-0754-3373

OpenAlex ID: A5017053233

Cytokine release syndrome associated with immune checkpoint inhibitors: a pharmacovigilance study based on spontaneous reports in FAERS

2024 · Xin Xi, Xida Yan, et al. · Expert Opinion on Drug Safety · 10

Immune checkpoint inhibitor‐associated bullous pemphigoid: A retrospective and real‐world study based on the United States Food and Drug Administration adverse event reporting system

2024 · Haowen Tan, Xiubi Chen, et al. · The Journal of Dermatology · 9

Single-cell RNA sequencing reveals the intra-tumoral heterogeneity and immune microenvironment of small cell carcinoma of the ovary, hypercalcemic type

2025 · Yi Gao, Kewei Zheng, et al. · Journal of Ovarian Research · 8

Gastric-type endocervical adenocarcinoma in situ as the presenting feature in a mosaic STK11 pathogenic variant carrier with a Peutz-Jeghers syndrome child

2025 · Anqi Jiang, Yingfei Ye, et al. · Familial Cancer · 4

A Pharmacovigilance Study of Immune Checkpoint Inhibitor‐Associated Cholangitis: Insights From the FDA Adverse Event Reporting System

2025 · Haowen Tan, Xuan Ou, et al. · Hepatology Research · 1

Post-marketing safety assessment of mirvetuximab soravtansine: a disproportionality analysis based on the FDA Adverse Event Reporting System

2026 · Haowen Tan, Xuan Ou, et al. · Journal of Gynecologic Oncology

Phytochemistry, Pharmacology And Therapeutics Of Coptis: Panacea For Multiple Diseases?

2016 · Haowen Tan, L Wang, et al. · The HKU Scholars Hub (University of Hong Kong)

Works count: 7

Citation count: 32

H-index: 4

I10-index: 1